Boston Scientific To Buy Medtech Co. Axonics In $3.7B Deal
Boston Scientific Corp. said Monday it has agreed to acquire medical technology company Axonics Inc. for $3.7 billion, in a push to expand its urology portfolio with technologies used to treat...To view the full article, register now.
Already a subscriber? Click here to view full article